BLI

NASDAQ:BLI

Berkeley Lights, Inc.

Add to Watchlist
  • Stock

1.20

−5.88%

−0.07

USD last updated 14/08 01:46:41

Last Close

1.27

21/03 20:00

Market Cap

86.61M

Beta: 1.36

Volume Today

2.29M

Avg: 815.46K

PE Ratio

−0.91

PFCF: −1.42

The global hydroxyapatite (HA) market is projected to grow from USD 583.1 million in 2025 to USD 1.2 billion by 2035, driven by biomedical applications in orthopedic implants, dental care, and biocompatible bone grafts. Key drivers include AI-driven biomaterials research, nano-hydroxyapatite innovations, and green-sourced extraction methods. Leading companies like DePuy Synthes, Colgate-Palmolive, and Berkeley Advanced Biomaterials Inc. are investing in high-purity HA development and sustainable production.

openpr.com

The single-cell omics market is projected to grow from USD 6.75 billion in 2025 to USD 16.92 billion by 2032, driven by advancements in genomics, transcriptomics, and proteomics. Key trends include rising adoption of single-cell sequencing, integration of AI/ML for data analytics, and expansion into oncology and immunotherapy. Regional growth is highlighted in Asia Pacific, with increased investment in biotechnology hubs and multi-omics integration.

openpr.com

Secured Retirement Advisors LLC trimmed its holdings in Lowe's Companies, Inc. (NYSE:LOW) by 62.9% in Q1, reducing its position to $702,000. Multiple hedge funds adjusted their positions, with Berkeley Inc., Asset Dedication LLC, and others increasing or acquiring shares. Insider activity included an EVP selling shares, and analysts updated price targets. Lowe's reported Q1 earnings exceeding expectations, with a dividend increase and key financial metrics.

marketbeat.com

UC Berkeley is planning to launch a new venture capital (VC) fund this year, aiming to support startups and innovation in the Bay Area. The initiative is expected to bring significant investment opportunities to the region, particularly in technology and biotech sectors.

bizjournals.com

The second annual Healthcare Conference Taipei, co-organized by UC Berkeley and J.P. Morgan, took place in February 2025, bringing together leading biotech and health tech startups and investors from across Asia and the U.S. The event aimed to accelerate the development of diagnostics, therapeutics, and technologies to prevent disease and save lives by fostering cross-border partnerships between the U.S. and Asia.

publichealth.berkeley.edu

    Description

    Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It s...Show More

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-12019-03-312020-03-312021-05-112022-05-092023-05-08

    Revenue (Estimate*)

    5M10M15M20M25M30M2019-03-312020-03-312021-05-112022-05-092023-05-08

    *Estimate based on analyst consensus